Bionetix Therapeutics

About:

Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment.

Website: http://www.bionetixrx.com/

Top Investors: Mirae Asset Venture Investment, Partners Investment, K Partners, Ost Investment

Description:

Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.

Total Funding Amount:

$12.3M

Headquarters Location:

Suwon, Ch'ungch'ong-namdo, South Korea

Founded Date:

2017-01-01

Founders:

Doo Young Jung, Hyun Cho, Jin Soo Lee

Number of Employees:

1-10

Last Funding Date:

2020-01-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai